期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
A strategy to produce monoclonal antibodies against gp96 by prime-boost regimen using endogenous protein and E.coli heterologously-expressed fragment 被引量:1
1
作者 张誉丹 操胜 +1 位作者 孟颂东 高福 《Journal of Central South University》 SCIE EI CAS 2011年第6期1857-1864,共8页
Gp96, a member of HSP90 family, is a versatile molecular chaperone with various newly-discovered functions, for example to serve as a low affinity, high capacity calcium binding protein, a natural adjuvant for therape... Gp96, a member of HSP90 family, is a versatile molecular chaperone with various newly-discovered functions, for example to serve as a low affinity, high capacity calcium binding protein, a natural adjuvant for therapeutic cancer vaccines, a tumor rejection antigen, an immune regulator to pathological cell death. Its multi-functional and structural characteristics make it also an interesting target to develop antibody-based therapeutics. However, its low immunogenicity to mice, because of its high-sequence similarity among different species, is an obstacle to obtain valuable monoclonal antibodies (MAbs). This is a common problem for any low immunogenic proteins, whose sequences share close identity between mice and other species. Here, a new strategy of priming was employed by swine endogenous full-length gp96 and then boosting by E. coli-system heterologously expressed gp96 N-terminal fragment (N-355) to generate MAbs. Twelve different highly-specific MAbs against swine/human endogenous gp96 were successfully obtained. The binding activities of these MAbs were confirmed by enzyme-linked immunosorbent assay (ELISA), Western blot (WB), immunofluorescence and flow cytometry analysis. This provides some important reagents for further research and potential therapeutics. The methods employed can be used for MAb production of any sequence-highly-conserved proteins between mice and swine/human (or any other species). 展开更多
关键词 monoclonal antibody priming-boost GP96 low immunogenic protein
在线阅读 下载PDF
Synthesis and Identification of SG-BSA and SG-OVA
2
作者 Zhu Ze-yao Zhan Chun-xia Zhang Qi-zhong 《Journal of Northeast Agricultural University(English Edition)》 CAS 2014年第2期62-67,共6页
Hapten sulfaguanidine (SG) was coupled with carrier protein bovine serum albumin (BSA) to form a full antigen SG- BSA by diazotization and glutaraldehyde methods. Ovalbumin (OVA) was used as protein carrier to c... Hapten sulfaguanidine (SG) was coupled with carrier protein bovine serum albumin (BSA) to form a full antigen SG- BSA by diazotization and glutaraldehyde methods. Ovalbumin (OVA) was used as protein carrier to couple with Hapten SG by glutaraldehyde method. Then, the immunogen and the coating antigen were purified by dialysis and gel exclusion chromatography. The conjugated ratio of SG to BSA in artificial antigen was 5.3 (using diazotization method) and 6.5 (glutaraldehyde method), and the conjugated ratio of SG to OVA in coating antigen was 2.3 (glutaraldehyde method) by UV-visible spectrophotometer. The coupling was successful according to the analysis of sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). BALB/c mice were immunized with the antigen (SG-BSA), and the titers of antiserum were tested to be 1 : 6 400 and 1 : 400 after three periods of immunities by indirect ELISA, which further identified the success of the synthesis of both immunogen SG-BSA and coating antigen SG-OVA. 展开更多
关键词 sulfaguanidine (SG) IMMUNOGEN coating antigen ELISA
在线阅读 下载PDF
ImmunoGen公司对蓖麻毒蛋白双链分子和抗体的复合体进行临床试验
3
作者 孙国凤 《生物技术通报》 CAS CSCD 1990年第8期11-12,共2页
1989年10月份在美国进行给成人骨髓细胞性白血病的晚期患者注射蓖麻毒蛋白的临床试验.蓖麻毒蛋白是毒性最强的毒素之一,连续5天,静脉注射了它的完整分子.试验目的是测定只针对白血病肿瘤细胞的单克隆抗体上结合了蓖麻毒蛋白后的安全性.
关键词 蓖麻毒蛋白 IMMUNOGEN 临床试验 髓细胞性白血病 白血病肿瘤细胞 单克隆抗体 复合体 人骨 骨髓性白血病 化学疗法
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部